title: Favorable outcome of severe, extensive, granulocyte colony-stimulating factor-induced, corticosteroid-resistant Sweet's syndrome treated with high-dose intravenous immunoglobulin.
authors.affiliation: Real Hospital Português-Real Transplante de Medula Óssea, Recife, Brazil.
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Calixto
authors.forename: Yara
authors.initials: Y
authors.lastname: Menezes
authors.forename: Maurício
authors.initials: M
authors.lastname: Ostronoff
authors.forename: Alexandre
authors.initials: A
authors.lastname: Sucupira
authors.forename: Luis Fábio
authors.initials: LF
authors.lastname: Botelho
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Florencio
authors.forename: Monique
authors.initials: M
authors.lastname: Martins
authors.forename: Ana Patrícia
authors.initials: AP
authors.lastname: Souto Maior
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001706:Biopsy; D004351:Drug Resistance; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy*; D012074:Remission Induction; D012720:Severity of Illness Index; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D016463:Sweet Syndrome / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D016756:Immunoglobulins, Intravenous; D016179:Granulocyte Colony-Stimulating Factor